| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:652-659.)
© 2004 American Heart Association, Inc.
Original Articles |
From the Cardiovascular Division, Brigham and Womens Hospital, Harvard Medical School, Boston, Mass.
Correspondence to Corinna Brunckhorst, MD, Cardiovascular Center, University Hospital Zurich, Ramistr. 100, 8091 Zurich, Switzerland. E-mail corinna.brunckhorst{at}usz.ch
Received February 13, 2004; revision received May 6, 2004; accepted May 7, 2004.
| Abstract |
|---|
|
|
|---|
Methods and Results Left ventricular pace mapping during sinus rhythm was performed at 819 sites in 11 patients with VT late after infarction, and corresponding CARTO maps were reconstructed. An isthmus site was defined by entrainment and/or VT termination by ablation. Pace-mapping data were analyzed from the identified isthmus site and from sites at progressively increasing distances from this initial isthmus site. Sites where pace mapping produced the same QRS with different S-QRS delays were identified to attempt to trace the course of the isthmus. In 11 patients, 13 confluent low-voltage infarct regions were present. In all these regions, parts of VT isthmuses were identified by pace mapping. In 11 of 13 of the identified isthmus parts, the QRS morphology of the pace map matched a VT QRS. In 10 of 11 patients, radiofrequency ablation rendered clinical VTs noninducible. Successful ablation sites were localized within an isthmus identified by pace mapping in all of these 10 patients.
Conclusions VT isthmuses can be identified and part of their course delineated by pace mapping during sinus rhythm. This method could help target isthmus sites for ablation during stable sinus rhythm.
Key Words: tachycardia mapping catheter ablation myocardial infarction
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
2 episodes of sustained monomorphic VT within the preceding 6 months. The number of inducible VTs was 4.4±2.2 (range 2 to 10; Table 1). All but 1 patient had an implantable cardioverter defibrillator, which had been implanted previously. All patients had failed antiarrhythmic drug therapy.
|
Mapping and Ablation
Patients underwent catheter mapping and ablation according to a protocol approved by the Human Research Committee of Brigham and Womens Hospital. After written informed consent was obtained, 6F multielectrode catheters were inserted percutaneously and positioned in the high right atrium, at the His position, and in the right ventricular apex. Left ventricular mapping used either a retrograde aortic or transseptal approach. Systemic anticoagulation with heparin was adjusted to an activated clotting time >250 seconds. Conscious sedation was achieved with intermittent administration of fentanyl and midazolam.
Catheter position was monitored and 3D anatomic reconstructions of left ventricular sites were displayed with the nonfluoroscopic mapping system CARTO (Biosense; Cordis Webster).4 A specially designed software program displayed voltage and S-QRSinterval maps and electrograms, the 12-lead ECG of each left ventricular site, and VT data. The 7F 4-mm-tip quadripolar mapping and ablation catheter has spacings of 1, 7, and 4 mm between electrodes. Bipolar electrograms from the distal electrodes of the mapping catheter were filtered at 10 to 400 Hz. The surface ECG leads were also stored on optical disc on a separate system (Prucka Engineering).
The initial step of the procedure included voltage mapping and pace mapping (see below) during stable sinus rhythm. The geometry of the left ventricle was defined, local electrograms were acquired, and pace mapping was performed at each site. The maximum electrogram amplitude (peak to peak) from the distal electrode pair of the mapping catheter was measured automatically and displayed on corresponding maps. VT was then induced by programmed stimulation. At selected sites, endocardial electrograms were acquired in VT, and entrainment mapping was used to determine whether the site was in the reentry circuit.5
For analysis, any of the following criteria defined an isthmus site;3 (1) pacing at the site entrained VT with concealed fusion, with an S-QRS <70% of the VT cycle length and either an S-QRS that matched the electrogram QRS (±20 ms) or a postpacing interval tachycardia cycle-length difference
30 ms; (2) RF current application terminated VT without inducing ventricular ectopy; or (3) repeated VT termination occurred with catheter manipulation or pacing at the site, which prevented assessment of ablation during VT, and RF ablation abolished that inducible VT.
After ablation, programmed stimulation with up to 3 extrastimuli from 2 right ventricular sites using drive trains of 600 and 400 ms was performed to determine whether VTs were rendered noninducible. Successful VT ablation was defined as absence of inducible VT. VT modification was defined as absence of inducible clinical VT but with other monomorphic VTs remaining inducible.
At each stable left ventricular catheter location, pace mapping during sinus rhythm was performed. At isthmus sites, defined during VT, pace mapping in sinus rhythm was attempted after VT termination, with the mapping catheter being kept at the same location. Pace mapping was performed with unipolar stimuli (10 mA, 2 ms) from the distal electrode of the mapping catheter (cathode) and an electrode in the inferior vena cava (anode). The pacing cycle length was the same for each site in an individual patient (500 to 700 ms) and therefore was slightly above the sinus rate and slower than the rate of the induced VTs. The resulting 12-lead ECG morphology was stored from all sites with capture. Locations where pacing did not capture were marked with gray tags, which indicated dense scar. The S-QRS interval was measured to the onset of the QRS in the ECG lead with the shortest S-QRS by a custom, automated program and subsequently was adjusted by manual review. Electroanatomic maps of color-coded S-QRS intervals were reconstructed. Identified isthmus sites were marked on the map. Pace-mapping QRS morphologies were analyzed from the identified isthmus site and from sites at progressively increasing distances from this initial isthmus site. Sites where pace mapping produced the same QRS as that of the initial isthmus site with different S-QRS delays were identified to attempt to trace the course of the isthmus. A pace-mapping match was defined when 10 of 12 leads had the same morphology. The distance between the most distal site and the most proximal site of the matching isthmus sites was determined by a custom program.
| Results |
|---|
|
|
|---|
1.5 mV) regions were present, consistent with infarcts (Figure 1A). Infarct locations were inferior or posterior in 8, anterior in 1, and in 2 discrete regions in 2 patients (posterobasal and inferoseptal in 1 and anteroapical and inferoseptal in the other). All the sites with an S-QRS >40 ms were located in the low-voltage area (Figure 1B). In each infarct region, a definite isthmus site could be identified with mapping techniques in VT (Figure 2). Starting from this initial site, part of the VT reentry circuit isthmus could be identified by pace mapping in each infarct region (Figure 3
|
|
|
|
|
Before ablation, 4.4±2.2 (range 2 to 10) VTs were inducible per patient (Table 1). Of these 3.5±2 (range 2 to 9) VTs were ablated, such that no VTs were inducible in 5 patients (45%) and VTs were modified in 5 (45%). One procedure was stopped prematurely because of a peripheral embolus to the foot from the insertion site in the femoral artery. Successful ablation sites were localized within an isthmus identified by pace mapping in 10 patients.
| Discussion |
|---|
|
|
|---|
Analysis of the QRS morphology during pace mapping in sinus rhythm is a well-established method for ablation of focal VTs but has been less reliable for guiding ablation of scar-related VTs.911 Propagation in the diseased myocardium is not homogeneous, and small differences in catheter location can cause grossly different propagation wave fronts and resulting QRS complexes.9,1214a Regions of functional block, present during VT, may define propagation paths during tachycardia but not during pace mapping. However, the pace-mapping QRS morphology from a catheter located at or near the exit of a VT reentry circuit should usually produce a QRS morphology similar to that of VT. In the present study, a QRS match was defined as 10 of 12 leads with the same morphology.11,14a
Pace mapping in sinus rhythm also provides a measure of slow conduction, indicated by the interval between the stimulus and the QRS complex (S-QRS) exceeding 40 ms.11,14a Data in the present study showed that sites with an S-QRS delay were always in the infarct region, as identified by electrogram voltage. It is likely that pacing sites with long S-QRS delays are in a potential isthmus, adjacent to regions of conduction block.
The relationship between conduction time, pacing site location in the isthmus, and conduction block determines whether pace mapping in an isthmus produces a QRS that resembles that of VT. When pace mapping in a defined isthmus is performed, the stimulated wave front can only follow along its course, which occurs in at least 2 directions: the orthodromic and antidromic direction of the VT propagation. The wave front is only detected on the surface ECG when it leaves this protected channel. If the isthmus is long and the catheter is positioned in the distal part, near the exit, the orthodromic wave front leaves the exit and rapidly depolarizes the region along the infarct, colliding with and preventing emergence of the antidromic wave front from the infarct region. The resulting QRS complex is then similar to that of VT. If the isthmus is short, or the catheter is positioned more proximally, the stimulated antidromic wave front leaves the protected isthmus at the entrance, propagating to the surrounding myocardium and producing a different QRS morphology. If the orthodromic wave front reaches the exit, a fusion QRS is produced that includes depolarization from both antidromic and orthodromic wave fronts.
The presence of functional, rather than fixed, areas of block could also importantly influence these findings. If block defining an isthmus is present only during VT and is absent during pace mapping in sinus rhythm, the stimulated wave front produced by pace mapping at the isthmus site would propagate in all directions. We performed pace mapping at rates slower than the VT, which may reduce the likelihood of functional block or lines of functional block. The slower pacing rate was used because each patient had several VTs, and rapid pacing is likely to induce VT, which would prevent analysis of pace mapping and complicate the mapping procedure. Despite the difference between pacing rate and VT cycle length, we were able to identify isthmus sites with pace mapping in all the infarct areas, although only the exit of the isthmus was identified in 1 region. In 11 (85%) of these 13 isthmus segments, the QRS morphology matched 1 of the induced VT morphologies, and in the 10 with multiple isthmus parts identified, the S-QRS interval was progressively longer as the site moved along the isthmus (Figure 3
), consistent with pacing progressively further from the exit.
The reentry circuit exit, which is more likely to be at the border of the infarct and close to the normal myocardium, often has no delay during pace mapping in sinus rhythm even though it is a desirable target for ablation.15 In 1 of the patients in the present study, only the exit site of the isthmus was identified, which had a short S-QRS of 26 ms. Pacing at surrounding sites produced different QRS morphologies, possibly indicating that the circuit dove deep to the endocardium, or functional block defined the circuit during VT and was absent during pace mapping. In 2 (15%) of the 13 identified isthmus parts, pace mapping did not match either of that patients induced VTs, although a long S-QRS interval was present. These findings are consistent with pace mapping at proximal isthmus sites, with propagation away from the circuit in the antidromic direction, as discussed above. The longest S-QRS intervals of the identified isthmus parts with a mean of 94±33 ms (excluding the one in which only the exit was identified) were much shorter than the longest S-QRS intervals of all sites in each patient, with a mean of 160±70 ms (P<0.05). The long S-QRS sites may be more proximal in isthmuses, where the antidromic wave front during pace mapping is able to propagate away from the reentry circuit, producing a QRS different from that of VT. These observations are consistent with a previous study showing that 66% of the sites at which the pace-mapping QRS complex resembled VT had an S-QRS interval <120 ms during entrainment, but in 89% of reentry circuit isthmus sites at which pace mapping did not match the VT QRS, the S-QRS during entrainment was
120 ms.11 This is a likely explanation for the observation that the longest S-QRS sites in most patients did not match any of the induced VTs. It is also possible that some of these long S-QRS sites were located in bystander regions of abnormal conduction. A bystander of 1 VT circuit can be a critical isthmus of another circuit, so that ablation in these areas might also be appropriate.
The observation that only 1 isthmus per infarct region was identified in patients in the present study may be due in part to the use of that isthmus for multiple VTs with different exits, such that ablation of that isthmus abolished more than 1 VT. Alternatively, extending the ablation across the isthmus to a site of inexcitable scar may have abolished other isthmuses. The remaining 13 VTs that were still inducible at the end of the procedure most likely used isthmuses that were not ablated, possibly because of an intramural or epicardial location.
In contrast to previous pace-mapping studies, the present investigation used electroanatomic mapping with exact anatomic localization of the S-QRS intervals and their morphologies and of the acquired parameters during VT. For the first time, it was therefore possible to correlate sinus rhythm pace mapping and VT data on a 3D reproduction of the left ventricle and display the precise location of part of the VT reentry circuit isthmuses.
Study Limitations
Patients in the present study were referred for catheter ablation and therefore were selected. The number of patients was relatively small. A match between S-QRS pace mapping and VT was determined as
10/12 and not as an exact match of 12/12, as in idiopathic VTs. Because of clinical and time restraints, sampling of sites was not homogeneous. Only limited isthmus sites were identified in VT, and the whole VT circuit was not outlined, so the pace mapping data were related only to the available VT data. The efficacy of ablation targeting the areas of isthmuses identified by pace mapping without mapping during VT is not known.
There are several caveats in interpretation of S-QRS delay with our methods. All patients in the present study were treated with antiarrhythmic drugs, and their influence on conduction could not be altered. Unipolar pacing was used to avoid changes that can be produced by capture from the proximal ring electrode when this is used as the anode.12,16 A fixed stimulus strength was used to facilitate rapid assessment during these procedures. Stimulus strength influences the size of the virtual electrode directly depolarized by the stimulus and can thus influence conduction away from the pacing site.1619 The stimulus current was applied to a large-surface-area ablation electrode, which reduces the current density at the electrode tip compared with that observed with standard-sized electrodes.19
Conclusions
Parts of VT reentry circuit isthmuses can be traced during sinus rhythm by combining both the QRS morphology and the S-QRS delay from pace mapping in anatomic maps. Ablation within these isthmuses abolishes VT that utilizes that isthmus. This method may facilitate ablation of stable and unstable VTs during sinus rhythm, but further study is required to determine whether it is sufficiently accurate to be the sole guide for ablation.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Sasano, M. R. Abraham, K.-C. Chang, H. Ashikaga, K. J. Mills, D. P. Holt, J. Hilton, S. G. Nekolla, J. Dong, A. C. Lardo, et al. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2266 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Eckart and L. M. Epstein Interventional Therapy for Atrial and Ventricular Arrhythmias Card. Surg. Adult, January 1, 2008; 3(2008): 1357 - 1374. [Full Text] |
||||
![]() |
R. E. Eckart, T. W. Hruczkowski, U. B. Tedrow, B. A. Koplan, L. M. Epstein, and W. G. Stevenson Sustained Ventricular Tachycardia Associated With Corrective Valve Surgery Circulation, October 30, 2007; 116(18): 2005 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Stevenson and K. Soejima Catheter Ablation for Ventricular Tachycardia Circulation, May 29, 2007; 115(21): 2750 - 2760. [Full Text] [PDF] |
||||
![]() |
H. U. Klemm, R. Ventura, D. Steven, C. Johnsen, T. Rostock, B. Lutomsky, T. Risius, T. Meinertz, and S. Willems Catheter Ablation of Multiple Ventricular Tachycardias After Myocardial Infarction Guided by Combined Contact and Noncontact Mapping Circulation, May 29, 2007; 115(21): 2697 - 2704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schmidt, C. F. Azevedo, A. Cheng, S. N. Gupta, D. A. Bluemke, T. K. Foo, G. Gerstenblith, R. G. Weiss, E. Marban, G. F. Tomaselli, et al. Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction Circulation, April 17, 2007; 115(15): 2006 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bogun, E. Good, S. Reich, D. Elmouchi, P. Igic, K. Lemola, D. Tschopp, K. Jongnarangsin, H. Oral, A. Chugh, et al. Isolated Potentials During Sinus Rhythm and Pace-Mapping Within Scars as Guides for Ablation of Post-Infarction Ventricular Tachycardia J. Am. Coll. Cardiol., May 16, 2006; 47(10): 2013 - 2019. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |